Wells William McDowall 4
4 · ACADIA PHARMACEUTICALS INC · Filed Jun 11, 2012
Insider Transaction Report
Form 4
Wells William McDowall
Director
Transactions
- Award
Stock Option (right to buy)
2012-06-08+44,117→ 44,117 totalExercise: $1.36Exp: 2022-06-07→ Common Stock (44,117 underlying) - Award
Stock Option (right to buy)
2012-06-08+10,000→ 10,000 totalExercise: $1.36Exp: 2022-06-07→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant.
- [F2]The Reporting Person has elected to convert annual retainer fees of $20,000 into a stock option under the terms of the Issuer's Outside Director Compensation Program.